1. The Role of the Urokinase-Type Plasminogen Activator System In Tumor Progression
   E. V. Kugaevskaya et al, 2019, Biochemistry (Moscow), Supplement Series B: Biomedical Chemistry CrossRef
2. Targeted therapy of chronic liver diseases with the inhibitors of angiogenesis
   Ankita Srivastava et al, 2018, Biomedicine & Pharmacotherapy CrossRef
3. Clinical significance of urinary plasminogen and fibrinogen gamma chain as novel potential diagnostic markers for non-small-cell lung cancer
   Wencheng Zhang et al, 2020, Clinica Chimica Acta CrossRef
4. The Role of Fibrinolytic Regulators in Vascular Dysfunction of Systemic Sclerosis
   Yosuke Kanno, 2019, International Journal of Molecular Sciences CrossRef
5. Integrated Analysis to Identify a Redox-Related Prognostic Signature for Clear Cell Renal Cell Carcinoma
   Yue Wu et al, 2021, Oxidative Medicine and Cellular Longevity CrossRef
6. Plasmin(ogen) serves as a favorable biomarker for prediction of survival in advanced high-grade serous ovarian cancer
   Shuo Zhao et al, 2017, Biological Chemistry CrossRef
7. The urokinase-type plasminogen activator system and its role in tumor progression
   E.V. Kugaevskaya et al, 2018, Biomeditsinskaya Khimiya CrossRef